CDK 4/6 inhibitors: Management of side effects

Share :
Sorry, this item is currently unavailable.
Published: 15 Nov 2016
Views: 2967
Rating:
Save
Dr Alison Jones - The LOC, London, UK

Dr Jones speaks at EONS 10, considering the side effects of CDK inhibition, including a class-wide tendency towards neutropenia, and how they might be managed with dose interruption.

CDKs were also discussed at an ecancer symposium at ESMO 2016.

Supported by a grant from Pfizer Inc.